{"id":"https://openalex.org/W2044632501","doi":"https://doi.org/10.1016/j.bmcl.2013.02.017","title":"Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer\u2019s disease","display_name":"Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer\u2019s disease","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-18","ids":{"openalex":"https://openalex.org/W2044632501","doi":"https://doi.org/10.1016/j.bmcl.2013.02.017","mag":"2044632501","pmid":"https://pubmed.ncbi.nlm.nih.gov/23481643"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2013.02.017","doi":"https://doi.org/10.1016/j.bmcl.2013.02.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.02.017","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2044632501"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bmcl.2013.02.017","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017542552","display_name":"Alejandro Romero","orcid":"https://orcid.org/0000-0001-5483-4973","observed_orcids":["https://orcid.org/0000-0001-5483-4973"]},"institutions":[{"id":"https://openalex.org/I121748325","display_name":"Universidad Complutense de Madrid","ror":"https://ror.org/02p0gd045","country_code":"ES","type":"education","lineage":["https://openalex.org/I121748325"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alejandro Romero","raw_affiliation_strings":["Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040-Madrid, Spain","Department of Toxicology & Pharmacology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology and Pharmacology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040-Madrid, Spain","institution_ids":["https://openalex.org/I121748325"]},{"raw_affiliation_string":"Department of Toxicology & Pharmacology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain","institution_ids":["https://openalex.org/I121748325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004538565","display_name":"Ram\u00f3n Cacabelos","orcid":"https://orcid.org/0000-0002-0554-4037","observed_orcids":["https://orcid.org/0000-0002-0554-4037"]},"institutions":[{"id":"https://openalex.org/I4210118861","display_name":"EuroEspes Biomedical Research Center","ror":"https://ror.org/02er0sb79","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210118861"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ram\u00f3n Cacabelos","raw_affiliation_strings":["EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine, 15166-Corunna, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine, 15166-Corunna, Spain","institution_ids":["https://openalex.org/I4210118861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090196837","display_name":"Mar\u00eda Jes\u00fas Oset\u2010Gasque","orcid":"https://orcid.org/0000-0002-7223-0222","observed_orcids":["https://orcid.org/0000-0002-7223-0222"]},"institutions":[{"id":"https://openalex.org/I121748325","display_name":"Universidad Complutense de Madrid","ror":"https://ror.org/02p0gd045","country_code":"ES","type":"education","lineage":["https://openalex.org/I121748325"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mar\u00eda J. Oset-Gasque","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, 28040-Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, Complutense University of Madrid, 28040-Madrid, Spain","institution_ids":["https://openalex.org/I121748325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018104052","display_name":"Abdelouahid Samadi","orcid":"https://orcid.org/0000-0003-1766-4471","observed_orcids":["https://orcid.org/0000-0003-1766-4471"]},"institutions":[{"id":"https://openalex.org/I4210162082","display_name":"Instituto de Qu\u00edmica Org\u00e1nica General","ror":"https://ror.org/05e0q7s59","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210162082"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Abdelouahid Samadi","raw_affiliation_strings":["Medicinal Chemistry Laboratory, Institute of General Organic Chemistry (CSIC), Juan de la Cierva, 3, 28006-Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Laboratory, Institute of General Organic Chemistry (CSIC), Juan de la Cierva, 3, 28006-Madrid, Spain","institution_ids":["https://openalex.org/I4210162082"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111604795","display_name":"Jose Luis Marco","orcid":"https://orcid.org/0000-0003-0690-0328","observed_orcids":["https://orcid.org/0000-0003-0690-0328"]},"institutions":[{"id":"https://openalex.org/I4210162082","display_name":"Instituto de Qu\u00edmica Org\u00e1nica General","ror":"https://ror.org/05e0q7s59","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210162082"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jos\u00e9 Marco-Contelles","raw_affiliation_strings":["Medicinal Chemistry Laboratory, Institute of General Organic Chemistry (CSIC), Juan de la Cierva, 3, 28006-Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry Laboratory, Institute of General Organic Chemistry (CSIC), Juan de la Cierva, 3, 28006-Madrid, Spain","institution_ids":["https://openalex.org/I4210162082"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017542552","https://openalex.org/A5111604795"],"corresponding_institution_ids":["https://openalex.org/I121748325","https://openalex.org/I4210162082"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":{"value":3880,"currency":"USD","value_usd":3880},"fwci":2.0317,"has_fulltext":false,"cited_by_count":168,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86458333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"23","issue":"7","first_page":"1916","last_page":"1922"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrine-derivatives","display_name":"tacrine derivatives","score":0.9359999895095825},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.925000011920929},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.4699999988079071},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.9883819818496704},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.796480655670166},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.6293564438819885},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5118993520736694},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4257826805114746},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.19550874829292297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.149358868598938},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13121074438095093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08094468712806702},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.bmcl.2013.02.017","doi":"https://doi.org/10.1016/j.bmcl.2013.02.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.02.017","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23481643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23481643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:digital.csic.es:10261/103416","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10261/103416","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"doi:10.1016/j.bmcl.2013.02.017","doi":"https://doi.org/10.1016/j.bmcl.2013.02.017","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.02.017","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W1547064889","https://openalex.org/W1596429639","https://openalex.org/W1940331911","https://openalex.org/W1965300654","https://openalex.org/W1965622867","https://openalex.org/W1966894026","https://openalex.org/W1973851363","https://openalex.org/W1974400337","https://openalex.org/W1976527379","https://openalex.org/W1977589519","https://openalex.org/W1980314143","https://openalex.org/W1983676080","https://openalex.org/W1989208794","https://openalex.org/W1998596454","https://openalex.org/W2000075945","https://openalex.org/W2000446523","https://openalex.org/W2000837493","https://openalex.org/W2001226246","https://openalex.org/W2002890802","https://openalex.org/W2004713321","https://openalex.org/W2006656242","https://openalex.org/W2009221410","https://openalex.org/W2011290762","https://openalex.org/W2019240871","https://openalex.org/W2021131416","https://openalex.org/W2026581284","https://openalex.org/W2026976753","https://openalex.org/W2027213068","https://openalex.org/W2027223952","https://openalex.org/W2030118227","https://openalex.org/W2033363151","https://openalex.org/W2041652663","https://openalex.org/W2042485050","https://openalex.org/W2046159507","https://openalex.org/W2046772199","https://openalex.org/W2051876980","https://openalex.org/W2053352254","https://openalex.org/W2057499077","https://openalex.org/W2062159889","https://openalex.org/W2062572062","https://openalex.org/W2070075494","https://openalex.org/W2071161708","https://openalex.org/W2073839993","https://openalex.org/W2073891844","https://openalex.org/W2076470489","https://openalex.org/W2078548071","https://openalex.org/W2084107396","https://openalex.org/W2084527204","https://openalex.org/W2089112315","https://openalex.org/W2092322803","https://openalex.org/W2106630611","https://openalex.org/W2107897308","https://openalex.org/W2121322934","https://openalex.org/W2124362440","https://openalex.org/W2132268401","https://openalex.org/W2135134122","https://openalex.org/W2144135498","https://openalex.org/W2155039139","https://openalex.org/W2320083125","https://openalex.org/W2323947867","https://openalex.org/W2326552962","https://openalex.org/W2473390500","https://openalex.org/W2952226466","https://openalex.org/W3023013291","https://openalex.org/W4233035841","https://openalex.org/W4238843899"],"related_works":["https://openalex.org/W2951871437","https://openalex.org/W2037061346","https://openalex.org/W2775729694","https://openalex.org/W7068097385","https://openalex.org/W4390394528","https://openalex.org/W3186747170","https://openalex.org/W7135615930","https://openalex.org/W2399512566","https://openalex.org/W2121322934","https://openalex.org/W2949660053"],"abstract_inverted_index":{"A":[0],"summary":[1],"of":[2,19],"the":[3,17],"recently":[4],"published":[5],"efforts":[6],"on":[7],"tacrine":[8],"derivatives":[9],"as":[10],"a":[11],"renewed":[12],"potential":[13],"therapeutic":[14],"approach":[15],"for":[16],"treatment":[18],"Alzheimer's":[20],"disease":[21],"is":[22],"presented.":[23]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2044632501","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
